Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
63.84
-0.64 (-0.99%)
At close: Mar 28, 2025, 4:00 PM
63.00
-0.84 (-1.32%)
After-hours: Mar 28, 2025, 6:54 PM EDT

Halozyme Therapeutics Employees

Halozyme Therapeutics had 350 employees as of December 31, 2024. The number of employees decreased by 23 or -6.17% compared to the previous year.

Employees
350
Change (1Y)
-23
Growth (1Y)
-6.17%
Revenue / Employee
$2,900,926
Profits / Employee
$1,268,831
Market Cap
7.86B

Employees Chart

Created with Highcharts 11.4.8Halozyme Therapeutics Employees20062007200820092010201120122013201420152016201720182019202020212022202320240100200300400500

Employees History

Date Employees Change Growth
Dec 31, 2024350-23-6.17%
Dec 31, 2023373-20-5.09%
Dec 31, 2022393248171.03%
Dec 31, 202114596.62%
Dec 31, 202013643.03%
Dec 31, 2019132-149-53.02%
Dec 31, 20182812610.20%
Dec 31, 2017255-4-1.54%
Dec 31, 20162594319.91%
Dec 31, 20152166341.18%
Dec 31, 2014153-17-10.00%
Dec 31, 20131701811.84%
Dec 31, 20121521712.59%
Dec 31, 20111353332.35%
Dec 31, 2010102-38-27.14%
Dec 31, 2009140107.69%
Dec 31, 20081303841.30%
Dec 31, 20079252130.00%
Dec 31, 200640--
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.